Local Institution

Canton, Ohio 44710

0 studies enrolling now · 10 studies all time

What they study most

Advanced Cutaneous Melanoma, Breast Cancer, Breast Neoplasms, Cancer, Congestive Heart Failure, Diabetes Mellitus II, Hypertension, Non-Small-Cell Lung Carcinoma, Rheumatoid Arthritis, Type 2 Diabetes Mellitus

Studies at this site

• A Multi-National, Prospective, Observational Study in Patients With Unresectable or Metastatic Melanoma — Completed
• Epothilone (Ixabepilone) Plus Capecitabine Versus Capecitabine Alone in Patients With Advanced Breast Cancer — Completed
• Randomized Study Evaluating Ixabepilone Plus Capecitabine or Docetaxel Plus Capecitabine in Metastatic Breast Cancer — Stopped early
• Study of Taxane/Carboplatin +/- Cetuximab as First-Line Treatment for Patients With Advanced/Metastatic Non-Small Cell Lung Cancer — Completed
• Irbesartan in Heart Failure With Preserved Systolic Function (I-Preserve) — Completed
• A Phase III Study of BMS-188667 in Subjects With Active Rheumatoid Arthritis — Completed
• Irbesartan/Hydrochlorothiazide (HCTZ) Combination Therapy for Patients With Moderate Hypertension — Completed
• Irbesartan/Hydrochlorothiazide (HCTZ) Combination Therapy as First Line Treatment for Severe Hypertension — Completed
• Study of Muraglitazar Versus Pioglitazone in Type 2 Diabetes — Completed
• Dose Ranging Study With LT, Monotherapy, PPAR — Completed